Nerve Health · Supplement Ingredient Guide

What Should a Nerve Health Supplement Contain? A Physician’s Ingredient Guide

A fellowship-trained peripheral nerve surgeon on why the label matters more than the marketing, and how to read one honestly.

Walk down the supplement aisle, or scroll a single page of search results, and the promises start to blur together. Repair your nerves. Regenerate damaged nerves. Reverse neuropathy. The instinct, when your feet burn at night or your fingertips have gone stubbornly numb, is to find the one bottle that undoes the damage. I understand that instinct completely. I also have to tell you, as someone who operates on peripheral nerves for a living, that it points you in almost exactly the wrong direction.

Here is the uncomfortable truth most nerve supplement marketing is built to avoid: no oral supplement has been shown in a controlled human trial to regenerate a damaged peripheral nerve. Not alpha-lipoic acid, not B12, not any proprietary blend with a hopeful name. That does not make these ingredients useless. Several of them have real, measurable evidence behind specific, narrower claims, and as you will see, a genuinely strong body of preclinical science behind their biological rationale. But the gap between supporting normal nerve function and repairing nerve damage is the entire ballgame, and it is precisely the distinction the label is designed to blur.

So instead of handing you a ranking of “best” products, I want to give you something more durable: the framework I would use to evaluate any nerve supplement on the shelf. Which ingredients have research behind them, which forms and doses actually matter, where the safety traps are, and how to tell an honest formula from a marketing exercise. By the end you should be able to read a supplement facts panel the way I do, and decide for yourself.

The Short Answer: There Is No Universally “Best” Nerve Health Supplement

If you searched “best supplement for neuropathy” to get here, I am not going to dodge the question, but I am going to reframe it. The best nerve health supplement is not the one with the longest ingredient list, the boldest claims, or the most five-star reviews. It is the one whose ingredients, forms, and doses are transparent, resemble what has actually been studied, are relevant to what is driving your particular symptoms, and avoid unnecessary risk. That is a moving target, because it depends on you: your likely cause, your nutritional status, your medications, and your metabolic health.

Nerve symptoms are a final common pathway for a long list of very different problems. A B12 deficiency, poorly controlled blood sugar, a compressed nerve at the wrist, the aftermath of chemotherapy, and an autoimmune process can all produce tingling, burning, and numbness. They do not respond to the same things. A nutrient that helps one will do nothing for another. This matters most for adults dealing with nerve discomfort or early neuropathy, especially after 40, when metabolic issues, medication use, and cumulative deficiencies become more common, and for anyone looking for clinician-formulated, evidence-backed support for nerve and metabolic health.

In the sections that follow, I will sort through what the research actually says about nerve repair, why specific nutrients such as B vitamins and antioxidants may help or cause problems, what the preclinical science shows, when a multi-pathway formula makes sense, why some supplements fail to deliver, and which safety alerts and label criteria matter before you buy. This is why “which supplement is best” is the wrong first question, and “what is actually causing my symptoms” is the right one.

Can Supplements Actually Repair or Regenerate Nerves?

This is the most-searched question in the entire category, so let me answer it plainly, from the perspective of someone who watches nerves heal after surgery. Peripheral nerves can regenerate. Oral supplements have not been proven to make that happen in humans.

When a peripheral nerve is injured, the portion downstream of the injury undergoes a process called Wallerian degeneration, clearing the old axon and its myelin. If the conditions are right, the axon can then regrow from the injury site outward, at a stubbornly fixed pace of roughly one millimeter per day, about an inch a month. I see this timeline play out in the clinic constantly. It is why a nerve repair near the elbow can take the better part of a year to reach the hand. That regeneration is a structural, cellular event driven by the nerve’s own biology and, when needed, by surgery that removes the compression or reconnects the ends.

No capsule has been shown to drive that structural process in a human trial. What the better-studied ingredients can plausibly do is different and narrower: correct a deficiency that was starving the nerve, reduce some of the oxidative and metabolic stress that impairs nerve function, and in a few studied populations, improve the symptoms a person reports. Those are real outcomes. They are also not the same as regrowing an axon or rebuilding myelin, and a company that treats them as interchangeable is telling you something about how it reads its own evidence.

Six outcomes get deliberately conflated in nerve marketing, and they are not equal: supporting normal nerve function, correcting a documented deficiency, improving symptoms in a studied group, changing an objective measurement like nerve conduction, repairing structural damage, and regenerating nerve tissue. Evidence for the first three exists in humans for several ingredients. Human evidence for the last three, from oral supplements, essentially does not exist yet, though as you will see, the animal and laboratory picture is more interesting than most people realize. Keep that hierarchy in your head and most of the hype collapses on contact.

Why a B-Complex Is Often an Incomplete Strategy

Many people treat nerve health as a B-vitamin problem, and reach first for a B-complex or a standalone B12. That is not wrong, exactly. It is incomplete, and in one specific way it can backfire.

B12: powerful when you are deficient, uncertain when you are not

Methylcobalamin, the active form of vitamin B12, is genuinely important for nerves. B12 is required to maintain the myelin sheath and to support normal nerve transmission. The people most likely to be quietly deficient are worth naming: long-term metformin users, in whom the drug can lower B12 levels by roughly 14 to 30 percent over time; people who eat little or no animal food; and older adults, whose absorption declines. If you are in one of those groups and have nerve symptoms, checking and correcting B12 is one of the highest-yield things you can do. More broadly, vitamin B status matters too, since thiamine, B6, folate, and B12 are all linked with nerve health.

Here is the honest limit. In people who are not deficient, the evidence that adding more B12 reverses established neuropathy is limited. It may help stabilize symptoms; it does not reliably undo objective damage. And the form matters: methylcobalamin is preferred over cyanocobalamin for neurological use by broad consensus, even though head-to-head trial data is thin. A 2026 trial in patients with diabetic neuropathy and low B12 found that 1,000 micrograms and 2,000 micrograms of oral B12 improved symptoms about equally, which tells you that past a certain point, more is not automatically better.

Vitamin B6: the ingredient where more is actively harmful

This is the single most important safety point in the entire category, and most consumers have never heard it. Vitamin B6, in excess, causes the exact sensory neuropathy people take it to avoid. Chronic high-dose pyridoxine is a documented cause of nerve damage. Regulatory bodies set a safe supplemental intake around 21 milligrams per day, with a tolerable upper limit of 25 to 100 milligrams depending on the authority, and case reports of neuropathy exist at intakes as low as 24 to 40 milligrams per day in susceptible people.

Now go read the label on many “nerve support” products. You will find 50 to 100 milligrams of B6, marketed as a benefit. For a product aimed at people worried about neuropathy, that is close to backwards. A conservative formula keeps B6 low, in the range of 10 milligrams, comfortably under every safety threshold. This one number is one of the fastest ways to sort a thoughtfully built formula from a thoughtlessly built one.

Benfotiamine: not the same as the thiamine in your B-complex

Benfotiamine is a fat-soluble form of vitamin B1 (thiamine) with substantially higher bioavailability and tissue penetration than the standard water-soluble thiamine in a typical B-complex. Mechanistically it is interesting for metabolic nerve stress: it helps limit the formation of advanced glycation end products, one of the pathways by which high blood sugar damages nerves.

The clinical picture is worth understanding, because it reveals a design principle behind any serious formula. Short-term trials (BEDIP and BENDIP) showed benfotiamine improving neuropathy symptom scores, with stronger effects near 600 milligrams per day. A longer 12-month trial (BOND, 2026) tested benfotiamine on its own, in people with established, longer-standing diabetic neuropathy, and did not find a significant benefit over that year. Read carefully, that is not evidence that benfotiamine does nothing. It is evidence about a specific and narrow test: one isolated ingredient, given by itself, in advanced disease where nerve loss may already be fixed.

Benfotiamine works on the glucose-and-glycation lane of nerve stress. It was never built to carry oxidative, mitochondrial, and microvascular stress on its own, and a trial that asks it to do so is asking a single tool to do a multi-tool job. This is precisely the reasoning behind a multi-pathway approach: no one ingredient, tested alone, reflects what a formula built across several pathways is designed to do. That combined effect has to be described as rationale rather than proven outcome, because the specific combination has not been tested head to head. But the logic is sound, and it is why benfotiamine belongs alongside other pathways rather than sitting in a bottle by itself.

The Major Ingredients, and What the Evidence Actually Supports

Below is how I weigh the ingredients you will encounter most often. Nutrition plays a significant role in maintaining nerve health, and for each ingredient the question is the same: what population was studied, at what dose and form, and how strong is the result. I have ordered them roughly from best-evidenced to most speculative. Broadly, the key options fall into vitamins, antioxidants, and compounds studied for nerve support, and most of them target inflammation, oxidative stress, or nutrient deficiencies. Many still require further human research before their effectiveness can be considered settled.

Alpha-lipoic acid: the strongest oral evidence in the category

Alpha-lipoic acid (ALA) is an antioxidant that is both water- and fat-soluble, which lets it cross the blood-nerve barrier and help regenerate the body’s own antioxidant systems. Nerves are unusually vulnerable to oxidative stress because of their high energy demand, so this is a sensible target. Among all the ingredients here, ALA has the most substantial human evidence: multiple randomized trials and meta-analyses show statistically significant improvement in neuropathic symptoms like burning, numbness, and paresthesia in diabetic neuropathy, most consistently at 600 milligrams per day.

Two honest caveats. First, the intravenous form has the strongest (grade A) evidence; the oral form is statistically significant but its clinical magnitude is debated by treatment guidelines. Second, on form: the R enantiomer (R-ALA) is the biologically active version and has clearly better pharmacokinetics than the racemic (R/S) mixture. But nearly every major clinical trial used the racemic mixture, so R-ALA is best described as a pharmacokinetic upgrade with a sound rationale, not a form proven clinically superior in a head-to-head neuropathy trial. A formula using R-ALA is making a defensible choice; it is not entitled to claim better outcomes because of it.

Safety worth knowing: ALA can modestly lower blood sugar, and in people with diabetes it can lower blood glucose further, so anyone on insulin or a sulfonylurea should monitor glucose. It should be separated in time from levothyroxine, may interact with blood thinners, and in rare, genetically predisposed individuals it has been linked to a hypoglycemic autoimmune syndrome.

Acetyl-L-carnitine: promising for diabetic nerves, dangerous during certain chemo

Acetyl-L-carnitine (ALC) supports mitochondrial energy production, delivering fatty acids into mitochondria for fuel, and in laboratory and animal work it supports the neurotrophic signals (such as NGF) that nerve repair depends on. In diabetic neuropathy the human evidence is mixed but real: a meta-analysis found moderate benefit for neuropathic pain, and one multicenter trial found it non-inferior to methylcobalamin. Most of those trials used around 1,500 milligrams per day, so a product supplying 600 milligrams sits below the best-studied dose, worth noting when you compare labels.

The critical safety point: in a well-designed randomized trial, ALC actually worsened chemotherapy-induced neuropathy in breast cancer patients treated with taxanes, and the harm persisted at two years. Anyone on active taxane chemotherapy should not take acetyl-L-carnitine. A responsible product or brand will say so, not bury it.

N-acetylcysteine and CoQ10: strong mechanism, weaker clinical proof

N-acetylcysteine (NAC) is an antioxidant precursor to glutathione that may help reduce nerve oxidative stress and inflammation, with encouraging animal data, but the human evidence in neuropathy is thin and contradictory. Two trials in chemotherapy-induced neuropathy reached opposite conclusions. Its oral bioavailability is also modest, and neuropathy trials generally used at least 1,200 milligrams, so lower doses are essentially untested for this purpose.

Coenzyme Q10 (CoQ10) is a genuine cornerstone of mitochondrial energy production, and its antioxidant properties make it mechanistically attractive. But the most relevant randomized trial in diabetic neuropathy found no improvement in symptoms or nerve-conduction findings versus placebo, even though it improved antioxidant markers. There is a narrower, more interesting signal in people whose CoQ10 has been depleted by statins. As a general nerve-symptom fix, though, CoQ10 is supported by mechanism more than by human outcomes.

Curcumin: interesting, but mind the drug interactions

Curcumin, the active polyphenol in turmeric, is an antioxidant that reduces inflammation, with one small, short, open-label human trial suggesting benefit as an add-on for neuropathic pain, plus a genuinely strong preclinical literature we will come back to. It is almost always paired with piperine (from black pepper), which raises curcumin absorption roughly 20-fold. That same piperine, however, inhibits the CYP3A4 enzyme system and can raise blood levels of many common medications, including certain statins, blood thinners, and immunosuppressants. If you take prescription drugs, curcumin-with-piperine is the ingredient most likely to matter, and worth running past your physician or pharmacist.

Bromelain and serrapeptase: the environmental-support lane

These two proteolytic enzymes are the most-questioned ingredients in any nerve formula, so let me explain exactly why they earn a place in one, because it is a deliberate choice, not filler. Neither bromelain nor serrapeptase has a randomized trial in peripheral neuropathy, and I would never tell you they treat it. What they do have is well-characterized anti-inflammatory and fibrinolytic activity.

The tissue environment around a stressed or compressed nerve is not neutral. It involves inflammatory signaling, local swelling, and fibrin deposition, all of which add to the load a nerve is already carrying. Proteolytic enzymes are included to help modulate that local environment, supporting normal tissue comfort and a healthy inflammatory response around the nerve rather than acting on the nerve fiber itself. Think of them as environmental support: the lane aimed at the terrain the nerve sits in, not the axon. And it is not purely theoretical. In animal neuropathic-pain models, bromelain reduced pain behaviors and improved markers of nerve oxidative stress, and it has anti-neuroinflammatory effects in other nervous-system models. There is still no nerve-regeneration study and no human neuropathy trial for either enzyme, so I hold this lane to the lowest evidentiary bar in the formula. But “least proven” is not “included at random.” Both carry a mild bleeding risk, so they should be stopped about two weeks before any surgery.

Vitamin D3: dose is the whole question

Vitamin D3 matters for nerve biology, and supplementation improves neuropathic pain in people who are genuinely deficient. The practical catch is dose. Trials generally used 1,000 to 5,000 IU per day or more, so a formula supplying 800 IU is on the low side and may not be enough to correct a real deficiency on its own. If your vitamin D is low, treat that as its own project with your clinician rather than assuming a nerve formula covers it.

What the Preclinical Science Actually Shows

“Not yet tested in humans” is not the same as “shown not to work.” It means the question is still open, and the honest way to handle an open question is to look at the biological evidence that does exist and label it precisely. A finding in a petri dish is not a finding in a rat, and a finding in a rat is not a finding in a person. But when several ingredients show the same regeneration-supporting effects across independent laboratories, multiple injury models, and rigorous endpoints, that is a real body of evidence, and it is the reason these ingredients were chosen. Here is where that evidence honestly stands.

Keep the hierarchy in mind as you read: cell culture (a neuron growing in a dish), animal models (a rat sciatic nerve injured, then measured with electron microscopy and functional testing), and human trials. Most of the regeneration evidence for nerve-support ingredients sits in the first two tiers. That is genuinely informative about mechanism and plausibility. It is not proof of human nerve regeneration, and I will not present it as such.

The ingredients with real preclinical regeneration data

Methylcobalamin has some of the strongest animal evidence in the category. In rat nerve-crush and surgical-repair models it promotes Schwann cell activity, remyelination, and functional recovery, and it upregulates the growth-associated proteins (GAP-43, S100) that mark active axon regrowth, working through the Erk1/2 and Akt signaling pathways. In humans the signal is thinner and route-dependent: a controlled study using corneal confocal microscopy found that injected B12, not the oral tablet, improved a measure of small-fiber nerve architecture in diabetic patients. That is a hint of structural benefit, not proof of regeneration, and it is honest to say the oral evidence has not reached that bar.

Acetyl-L-carnitine has arguably the most dramatic animal findings here. In multiple rodent injury models it sharply increases axonal regrowth, myelination, and Schwann cell activity, and it appears to rescue sensory neurons that would otherwise die after injury, through upregulation of neurotrophic factors like NGF and artemin. In humans, one controlled study found improved nerve-fiber density in a specific population (HIV-associated neuropathy), which is one of the only human structural signals for any of these ingredients, although it does not generalize to diabetic or idiopathic neuropathy. The taxane-chemotherapy caution from earlier still stands.

Alpha-lipoic acid shows consistent animal regeneration data: in nerve-crush models it reduces degeneration of myelinated fibers, improves axon and myelin structure on electron microscopy, and calms the inflammatory response, while protecting Schwann cells from the glycation damage that drives diabetic nerve injury. The honest counterweight, which I include deliberately, is that a three-month oral trial in humans failed to improve nerve conduction. That is a useful reminder of how often the jump from animal doses and delivery to oral human dosing does not translate cleanly.

Curcumin has a large and rigorous animal literature: increased myelinated axons, Schwann cell proliferation and remyelination, and improvement even in a genetic demyelinating-neuropathy model, working through the Nrf2, Erk1/2, and Akt pathways. Its constraint is bioavailability. Most of those studies used delivery methods that achieve tissue levels an oral capsule cannot, which is exactly why it is paired with piperine, and why I am careful not to promise the animal results in a bottle.

Vitamin D3 and NAC round out the picture at a slightly lower tier. D3 improves axon diameter, myelin thickness, and remyelination in animal injury models and drives nerve-growth-factor expression in Schwann cells. NAC improves nerve healing and reverses myelin damage on electron microscopy in rat crush models, largely by restoring the nerve’s antioxidant defenses.

Why this matters for how a formula is built

Notice the pattern. These ingredients are not chosen because a marketing team liked the names. Each one has a mechanistic and preclinical rationale for participating in the biology of nerve repair: protecting Schwann cells, supporting remyelination, feeding the energy demands of a regenerating axon, calming the inflammatory environment, or supplying neurotrophic signals. The human confirmation, at the level of a controlled trial measuring nerve fibers, is still pending for oral supplementation. Both of those statements are true at the same time, and a physician should be comfortable saying both. The biology is real and points in a consistent direction. The human proof is not yet complete. That is a stronger, more honest foundation than either false certainty or dismissive doubt.

The Multi-Pathway Idea: Defensible Logic, Not Proven Superiority

Here is the argument for a combination formula, made honestly. Nerve dysfunction, especially the metabolic kind, is not driven by a single mechanism. In diabetic neuropathy alone, at least four processes run at once: vitamin and metabolic strain, oxidative stress, mitochondrial dysfunction, and impaired microcirculation to the nerve. A single ingredient, by design, addresses one lane. A formula built across several lanes is trying not to miss a relevant one. As biological logic, that is reasonable.

There is even early laboratory support for the combination idea itself. A 2025 cell-culture study found that vitamins B1, B6, and B12 together outperformed B12 alone for neural cell maturation and Schwann cell connectivity. That is a dish, not a person, and I hold it at exactly that level. But it is a real signal that these pathways may reinforce one another rather than acting in isolation.

But logic is not proof, and I will not pretend otherwise. No randomized trial has tested any complete multi-ingredient nerve formula, including the ones I would consider well-designed. The fact that several ingredients each show an effect in separate trials, in different populations at different doses, does not establish that combining them produces an additive or superior result. Combination formulas are biologically rational and largely untested as combinations. Any brand claiming its blend is “clinically proven” as a formula is claiming something no one has demonstrated.

There is also a limit to what any capsule can do while the upstream problem is ignored. If blood sugar is still running high, if a nerve is still compressed at the wrist, if alcohol intake is still doing damage, no supplement offsets that. Nutrition, activity, weight, and glucose control frequently matter more than adding another bottle.

A Nine-Point Checklist for Any Nerve Supplement

Run any product, including anything I might recommend, through these nine questions before you spend a dollar.

Why a Nerve Supplement May Not Seem to Work

Plenty of people take a reasonable supplement and feel nothing. That does not always mean the product is worthless. More often it means one of these is true, and most of them are fixable once you know to look.

• The cause was never identified. Much “idiopathic” neuropathy turns out to involve undiagnosed prediabetes or another treatable driver.
• The symptoms are not deficiency-driven. If nothing was nutritionally missing, replacing it changes little.
• Blood sugar is still dysregulated. Ongoing high glucose keeps injuring nerves faster than any capsule supports them.
• The dose or duration was too low. Trial benefits often took 8 to 24 weeks or longer; a few weeks is not a fair test.
• The form or absorption was poor. Cyanocobalamin instead of methyl, plain thiamine instead of benfotiamine, low-bioavailability ALA.
• A nerve is mechanically compressed. Carpal tunnel and similar entrapments are structural. No nutrient relieves compression.
• The damage is already irreversible. Established axonal loss, especially in large fibers, does not come back with current tools.
• Expectations were set by “regeneration” advertising that was never realistic.
• The supplement was treated as the entire solution, instead of one piece alongside diet, movement, and glucose control.

When Symptoms Need a Clinician, Not a Supplement

Some patterns are signals to stop shopping and get evaluated. From the surgical side, these are the ones I never want someone to sit on. Seek prompt medical assessment for:

• Rapidly progressive weakness developing over days to weeks.
• New foot drop, or a foot or hand that will not lift or grip.
• One-sided or clearly asymmetric symptoms, rather than a symmetric stocking-glove pattern.
• Any bowel or bladder change occurring alongside limb symptoms, which can be an emergency.
• Severe back or neck pain accompanying the neurological changes.
• Unexplained weight loss, or new nerve symptoms during cancer treatment.

These can reflect conditions that are serious, sometimes reversible, and entirely beyond what any supplement addresses. Ingredient literacy is valuable, but it is not a substitute for a diagnosis.

Where This Framework Points: How I Built NeuroAxis

I will be direct about my stake, because you should weigh it: I formulated NeuroAxis, and I built it around the framework in this article rather than reverse-engineering the framework to fit it. So hold it to the same nine questions. It discloses exact amounts for every ingredient, with no proprietary blend. It uses the forms the evidence favors: methylcobalamin (2,000 mcg), benfotiamine (300 mg), and R-alpha-lipoic acid (600 mg, matching the most-studied dose). It keeps vitamin B6 at 10 milligrams, deliberately on the safe side of every threshold, rather than the 50 to 100 milligrams that show up in many competitors and can themselves cause the neuropathy people are trying to avoid. And it works across the pathways this article has walked through, vitamin sufficiency, oxidative balance, mitochondrial energy, and the tissue environment, rather than betting everything on one.

That last point is the design philosophy. Nerve stress rarely runs down a single lane, and single ingredients tested alone, as we saw with benfotiamine, are being asked to do a job no one ingredient was built for. Every ingredient in the formula also carries the kind of mechanistic and preclinical rationale described above: a real reason, grounded in biology, to be there. A formula assembled across the pathways the research actually implicates is a more complete nutritional foundation than a basic B-complex or a lone bottle of one antioxidant. I want to be precise about the claim: this is a rationale grounded in ingredient-level evidence and nerve physiology, not a promise that the combination has been tested as a unit, because it has not. NeuroAxis is designed to support normal nerve function as one part of a broader strategy. It is not a treatment for neuropathy, and no honest formula, including this one, claims to repair or regenerate nerves. What it offers is a transparent, physician-formulated foundation built the way the biology suggests it should be built.

Two Sensible Next Steps

If you want a more complete nutritional foundation

If you already have a reasonable sense of your situation, you are currently taking only a B-complex or a single ingredient, and you want disclosed doses and better forms in one formula instead of assembling five bottles, NeuroAxis is built for exactly that. Explore the multi-pathway framework behind NeuroAxis.

If you are not sure what is driving your symptoms

If your testing has been normal or inconclusive, your symptoms are progressing or asymmetric, you take several medications, or you have metabolic issues you have not fully addressed, the smartest move is not another capsule. It is figuring out where the gaps are first. Book a free 10-minute nerve health discovery call and we will look at whether your current strategy has holes worth closing before you add anything.

Frequently Asked Questions

Can supplements repair or regenerate damaged nerves?

No oral supplement has been shown in a controlled human trial to regenerate peripheral nerve axons or rebuild myelin. That said, several ingredients (including methylcobalamin, acetyl-L-carnitine, alpha-lipoic acid, and curcumin) have demonstrated nerve-regeneration-supporting effects in animal and laboratory studies, such as axonal growth, Schwann cell activity, and remyelination. Those findings support the biological rationale of a nerve-health formula, but human nerve regeneration from oral supplementation has not been established. What the better-studied ingredients can do in people is narrower: correct a deficiency, reduce oxidative and metabolic stress, and improve symptoms in specific studied groups.

Is B12 good for neuropathy?

It depends on whether B12 is part of your problem. In people who are deficient, including many long-term metformin users, vegans, and older adults, correcting B12 with methylcobalamin can genuinely help. In people who are not deficient, the evidence that extra B12 reverses established neuropathy is limited. B12 is high-value when a deficiency exists and uncertain when it does not. More broadly, vitamin deficiencies are one reversible cause of neuropathy and should be checked before assuming supplements will help.

Is a B-complex enough for nerve health?

Often no. A B-complex addresses one pathway, vitamin sufficiency, and only when a deficiency is actually present. It does nothing for oxidative stress, mitochondrial strain, or ongoing glucose injury, which drive much of metabolic neuropathy. A B-complex with high-dose B6 can even work against you, since excess B6 causes neuropathy.

Can too much vitamin B6 cause neuropathy?

Yes. Chronic high-dose pyridoxine is a documented cause of sensory neuropathy, with a safe supplemental intake around 21 milligrams per day and case reports of nerve damage at intakes as low as 24 to 40 milligrams in some people. Many nerve products contain 50 to 100 milligrams, which is a reason to scrutinize the B6 line specifically. A conservative dose is around 10 milligrams.

What is benfotiamine, and how is it different from thiamine?

Benfotiamine is a fat-soluble form of vitamin B1 with much higher bioavailability and tissue penetration than the standard thiamine in a typical B-complex, and it targets the glucose-and-glycation pathway of nerve stress. Short-term trials showed symptom benefit; a 12-month trial (BOND, 2026) tested benfotiamine on its own in established diabetic neuropathy and did not show a significant benefit over that year. That result speaks to one isolated ingredient in advanced disease, not to benfotiamine’s role within a broader multi-pathway approach, which is why it is best used alongside other pathways rather than by itself.

Does the form of alpha-lipoic acid matter?

The R form (R-ALA) is the biologically active version and has better absorption than the racemic mixture. But nearly all the major clinical trials used racemic ALA, so R-ALA is a well-reasoned pharmacokinetic upgrade rather than a form proven clinically superior in a head-to-head neuropathy trial. The most-studied dose is 600 milligrams per day.

How long do nerve supplements take to work?

Plan on at least 8 to 12 weeks at meaningful doses before judging results. Clinical trials that showed benefit ran from a few weeks (for intravenous ALA) to 24 weeks (for acetyl-L-carnitine), and any structural change takes far longer. A two-week trial is not a fair test.

Why might my nerve supplement not be working?

The most common reasons are that the real cause was never identified, the symptoms were not driven by a deficiency, blood sugar is still dysregulated, the dose or duration was too low, the form absorbed poorly, a nerve is mechanically compressed, or the damage is already irreversible. It can also simply be too early, or the supplement is being asked to do a job that diet, movement, and glucose control need to do alongside it.

This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation.